HIV in 2019: it’s all about dolutegravir
This year’s IAS 2019 Conference on HIV Science, held in Mexico City on 21-24 July, featured new research on pre-exposure prophylaxis (PrEP), new drugs, and simplified treatment, but it was dominated…
Read Original Article: HIV in 2019: it’s all about dolutegravir »
